APOA1 and obesity disorder: Also, apoA-I mimetic peptides, D-4F and L-4F, reduced vascular inflammation induced by streptozotocin injection in Sprague-Dawley rat [17] and improved insulin sensitivity in a mouse model of diabetes and obesity [18].